The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A disease registry study to prospectively observe treatment patterns and outcomes in patients with HER2+ unresectable locally advanced or metastatic breast cancer (aBC): Interim results of the ESTHER study (NCT02393924).
 
Catherine Harper-Wynne
Honoraria - AstraZeneca; Everything Genetic; Exact Sciences; Gilead Sciences; Lilly O.; Novartis; Pfizer; Roche; Seagen
 
James Owen
Employment - Roche UK
Stock and Other Ownership Interests - Roche UK
 
Galina Velikova
Honoraria - Eisai; Roche UK; Sanofi; Seagen
Consulting or Advisory Role - Eisai; Novartis; Roche UK; Sanofi
Speakers' Bureau - Novartis
Research Funding - IQVIA (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Eisai; Novartis; Roche UK
Other Relationship - University of Leeds
 
Stephanie Sutherland
Honoraria - Seagen
Consulting or Advisory Role - Roche
 
Mircea Jivulescu
Employment - Cmed Clinical Research Services
 
Alistair E. Ring
Consulting or Advisory Role - AstraZeneca/Daiichi Sankyo; Lilly; MSD Oncology; Novartis; Pfizer; Roche UK; Seagen